News
Theratechnologies Q1 EPS $(0.10) Beats $(0.12) Estimate, Sales $16.25M Miss $20.10M Estimate
10 Apr 24
Earnings, News
Earnings Scheduled For April 10, 2024
10 Apr 24
Earnings
Theratechnologies Presents Preclinical Data That Highlight Versatility And Flexibility Of SORT1+ Technology Platform
8 Apr 24
News
Theratechnologies Announces Update On Its Preclinical Oncology Research Program; Company Will Continue To Prioritize Its Ongoing Phase 1 Clinical Trial Of Sudocetaxel Zendusortide In Patients With Advanced Ovarian Cancer
22 Mar 24
Biotech, News, General
Theratechnologies Q4 EPS $(0.08) May Not Be Comparable To $(0.24) Estimate, Sales $23.45M Beat $23.36M Estimate
21 Feb 24
Earnings, News
Earnings Scheduled For February 21, 2024
21 Feb 24
Earnings
Theratechnologies Earnings Preview
20 Feb 24
Earnings
Press releases
Theratechnologies Announces Mailing of Management Proxy Circular in Connection with its Annual Meeting of Shareholders
15 Apr 24
News, Management, Press Releases
Theratechnologies to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
11 Apr 24
News, Press Releases
Theratechnologies Reports Financial Results and Provides Business Update for First Quarter 2024
10 Apr 24
Earnings, Press Releases
Theratechnologies Preclinical Data Presentation at AACR 2024 Highlights Versatility and Flexibility of SORT1+ Technology™ Oncology Platform
8 Apr 24
Health Care, Press Releases
Theratechnologies Appoints Elina Tea to its Board of Directors
5 Apr 24
News, Management, Press Releases
Theratechnologies to Announce First Quarter 2024 Financial Results and Provide Business Update
3 Apr 24
Earnings, Press Releases
Theratechnologies to Present Preclinical Data at AACR on Multiple PDCs Showcasing Potential of SORT1+Technology™ Platform
28 Mar 24
News, Health Care, Press Releases
Theratechnologies Announces Update on its Preclinical Oncology Research Program
22 Mar 24
Health Care, Press Releases, General
Theratechnologies Appoints Jordan Zwick to its Board of Directors
21 Mar 24
News, Management, Press Releases
Theratechnologies Initiates Increased Dose Level in Phase 1 Clinical Trial of Sudocetaxel Zendusortide in Advanced Ovarian Cancer
21 Mar 24
Health Care, Press Releases
Theratechnologies Announces the Resignation of One of Its Directors, Mr. Alain Trudeau
29 Feb 24
News, Management, Press Releases
Theratechnologies Receives Refusal to File Letter for Trogarzo® Intramuscular Method of Administration sBLA from FDA
27 Feb 24
Health Care, Press Releases
Theratechnologies Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2023 and Provides 2024 Guidance
21 Feb 24
Earnings, News, Press Releases
Theratechnologies Completes Enrollment of First Six Patients in Updated Phase 1 Clinical Trial of Sudocetaxel Zendusortide in Advanced Ovarian Cancer
15 Feb 24
Health Care, Press Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Theratechnologies Inc. - THTX
11 Feb 24
News, Legal, Press Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Theratechnologies Inc. - THTX
7 Feb 24
Press Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Theratechnologies Inc. - THTX
6 Feb 24
Theratechnologies to Announce Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update
6 Feb 24
Earnings, News, Press Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Theratechnologies Inc. - THTX
3 Feb 24
News, Legal, Press Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Theratechnologies Inc. - THTX
30 Jan 24
Press Releases